Phase
Condition
Rosacea
Skin Wounds
Psoriasis And Psoriatic Disorders
Treatment
Deucravacitinib
Clinical Study ID
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participant aged 18 years or older
Physician-reported (dermatologist) diagnosis of moderate plaque psoriasis with BodySurface Area ≥ 3% and < 10%
Participant newly initiated deucravacitinib according to the label
Provided written informed consent to participate in the study
Exclusion
Exclusion Criteria:
Participating in or planning to participate in an interventional clinical trial
Concomitant use of other systemic treatments for psoriasis at baseline
Prior treatment of deucravacitinib
Study Design
Connect with a study center
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong 510091
ChinaSite Not Available
Local Institution - 0001
Guangzhou, Guangdong 510091
ChinaSite Not Available
Dermatology Hospital of Southern Medical University
Guangzhou 1809858, Guangdong 1809935 510091
ChinaSite Not Available
Local Institution - 0002
Handan, Hebei 056029
ChinaSite Not Available
The Affiliated Hospital of Hebei University of Engineering
Handan 1808963, Hebei 1808773 056029
ChinaSite Not Available
Local Institution - 0005
Dalian, Liaoning 116021
ChinaSite Not Available
DaLian Dermatosis Hospital
Dalian 1814087, Liaoning 2036115 116021
ChinaSite Not Available
Local Institution - 0004
Shanghai, Shanghai Municipality 200080
ChinaSite Not Available
Shanghai General Hospital
Shanghai 1796236, Shanghai Municipality 1796231 200080
ChinaSite Not Available
Local Institution - 0003
Beijing, 102218
ChinaSite Not Available
Beijing Tsinghua Changgung Hospital
Beijing 1816670, 102218
ChinaSite Not Available
Hangzhou Tigermed Consulting Co., Ltd.
HangZhou,
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.